Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma
Alexandre Ingels, Riccardo Campi, Umberto Capitanio, et al.
Nature Reviews Urology (2022) Vol. 19, Iss. 7, pp. 391-418
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression
Wenjin Chen, Xiuwu Pan, Xu Song, et al.
Cancer Letters (2024) Vol. 593, pp. 216963-216963
Closed Access | Times Cited: 10
F-box protein FBXO21 overexpression inhibits the proliferation and metastasis of clear cell renal cell carcinoma and is closely related to the CREB pathway and tumor immune cell infiltration
Wuping Yang, Taile Jing, Cunjin Wu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Nanocomposite pastes of gelatin and cyclodextrin-grafted chitosan nanoparticles as potential postoperative tumor therapy
Lin Xiao, Weichang Xu, Lixia Huang, et al.
Advanced Composites and Hybrid Materials (2022) Vol. 6, Iss. 1
Closed Access | Times Cited: 36
Effects of neoadjuvant VEGF‑TKI treatment on surgery for renal cell carcinoma: A systematic review and meta‑analysis
Meikai Zhu, Zhifeng Liu, Yongheng Zhou, et al.
Oncology Letters (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 5
Cooperation between SIX1 and DHX9 transcriptionally regulates integrin-focal adhesion signaling mediated metastasis and sunitinib resistance in KIRC
Shiyu Huang, Juncheng Hu, Min Hu, et al.
Oncogene (2024) Vol. 43, Iss. 39, pp. 2951-2969
Closed Access | Times Cited: 5
NCOA7 Regulates Growth and Metastasis of Clear Cell Renal Cell Carcinoma via MAPK/ERK Signaling Pathway
Jiayu Guo, Shuai Ke, Qi Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11584-11584
Open Access | Times Cited: 12
Genitourinary cancer neoadjuvant therapies: current and future approaches
Sujit S. Nair, Dimple Chakravarty, Vaibhav G. Patel, et al.
Trends in cancer (2023) Vol. 9, Iss. 12, pp. 1041-1057
Open Access | Times Cited: 11
Conversion surgery intervention versus continued systemic therapy in patients with a response after PD-1/PD-L1 inhibitor-based combination therapy for initially unresectable biliary tract cancer: a retrospective cohort study
Shanshan Wang, Yunchao Wang, Chengpei Zhu, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 4
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial
Jiwei Huang, Yueming Wang, Fan Xu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e008475-e008475
Open Access | Times Cited: 4
Silencing of APEX1 triggers ferroptosis in clear cell renal cell carcinoma via APP-mediated activation of p53/xCT signaling
Fang Huang, Hui Ling, Jie Wang
Experimental Cell Research (2025), pp. 114409-114409
Closed Access
PTEN suppresses renal cell carcinoma proliferation and migration via inhibition of the PI3K/AKT pathway
Xu Xu, Ya‐ling Tang, Xiaohong Liang, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Cytoreductive nephrectomy for oligometastatic clear cell renal cell carcinoma in the era of immuno-oncology
Laura Marandino, Veronica Mollica, Riccardo Campi
Current Opinion in Urology (2025)
Closed Access
CAR T-cell therapy in renal cell carcinoma: opportunities, challenges, and new strategies to overcome
Mahan Mohammadi, Houshang Najafi, Pantea Mohammadi
Medical Oncology (2025) Vol. 42, Iss. 6
Closed Access
Preoperative prediction of WHO/ISUP grade of ccRCC using intratumoral and peritumoral habitat imaging: multicenter study
Zhihui Chen, Hongqing Zhu, Hongmin Shu, et al.
Cancer Imaging (2025) Vol. 25, Iss. 1
Open Access
Combined Therapies in Renal Cell Carcinoma: The Challenge of Overcoming Resistance
Luis Enrique Malpica Castillo
JCO Oncology Practice (2025)
Closed Access
VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression
Jing Ji, Yuxin Xu, Mengru Xie, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 9
Prognostic and tumor microenvironmental feature of clear cell renal cell carcinoma revealed by m6A and lactylation modification-related genes
Lin Yang, Xiaoyu Wang, Jiahao Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy
Kazuyuki Numakura, Yuya Sekine, Takahiro Osawa, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 7, pp. 1019-1026
Closed Access | Times Cited: 3
The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in immune-oncology era (SEVURO-CN): study protocol for a multi-center, prospective, randomized trial
Jee Soo Park, Jong Chan Kim, Jinhyung Jeon, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Non-coding RNAs in renal cell carcinoma: Implications for drug resistance
Yiqi Liu, Hu Zhang, Yuan Fang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 115001-115001
Open Access | Times Cited: 7
GHITM regulates malignant phenotype and sensitivity to PD‐1 blockade of renal cancer cells via Notch signalling
Shiyu Huang, Jiachen Liu, Juncheng Hu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 2
Biomimetic Hydrogel‐Mediated Mechano‐Immunometabolic Therapy for Inhibition of ccRCC Recurrence After Surgery
Yunze Dong, Jun Luo, Mingliang Pei, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 2
KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway
Hao Deng, Xiaobo Gong, Guanghai Ji, et al.
Molecular and Cellular Probes (2023) Vol. 72, pp. 101938-101938
Open Access | Times Cited: 6
APOA1 mRNA and protein in kidney renal clear cell carcinoma correlate with the disease outcome
Wei Zeng, Guoguang Xiong, Li Hua, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Renal cell carcinoma with non-clear cell histologies: all the same peas in one pod?
Eduard Roussel, Daniele Amparore, Riccardo Bertolo, et al.
Minerva Urology and Nephrology (2023) Vol. 75, Iss. 4
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top